Rallybio Corp Q1 2025 Update: Equity Changes Detailed
Ticker: RLYB · Form: 10-Q · Filed: May 8, 2025 · CIK: 1739410
| Field | Detail |
|---|---|
| Company | Rallybio Corp (RLYB) |
| Form Type | 10-Q |
| Filed Date | May 8, 2025 |
| Risk Level | medium |
| Sentiment | neutral |
Sentiment: neutral
Topics: 10-Q, financials, equity
TL;DR
Rallybio Q1 2025: Equity accounts like common stock and APIC show changes. No revenue details here.
AI Summary
Rallybio Corp reported its first quarter 2025 results, ending March 31, 2025. The company's financial statements show changes in its equity accounts, including common stock and additional paid-in capital, over the periods ending December 31, 2023, and March 31, 2024. Specific revenue figures and operational details for the first quarter of 2025 are not detailed in this excerpt.
Why It Matters
This filing provides insight into Rallybio's financial structure and equity movements, which can influence investor confidence and future capital raising efforts.
Risk Assessment
Risk Level: medium — The filing details financial structure changes, which are important for investors but lack specific operational or revenue performance metrics for the current quarter.
Key Numbers
- 2025-03-31 — Reporting Period End Date (Indicates the end of the financial quarter being reported.)
- 2025-05-08 — Filing Date (Shows when the 10-Q was officially submitted to the SEC.)
Key Players & Entities
- Rallybio Corp (company) — Filer of the 10-Q
- 20250331 (date) — End of the reporting period
- 20250508 (date) — Filing date
- 2023-12-31 (date) — Prior period end date for equity comparison
- 2024-03-31 (date) — Prior period end date for equity comparison
FAQ
What were Rallybio Corp's total revenues for the first quarter of 2025?
This excerpt does not provide specific revenue figures for the first quarter of 2025. It focuses on equity account changes.
What is the significance of the changes in 'AdditionalPaidInCapitalMember' between December 31, 2023, and March 31, 2024?
Changes in Additional Paid-In Capital typically reflect funds raised from issuing stock above its par value, indicating potential equity financing activities.
What is the company's primary business as indicated by its SIC code?
Rallybio Corp's Standard Industrial Classification (SIC) code is 2834, which corresponds to Pharmaceutical Preparations.
When was Rallybio Corp previously known as Rallybio Holdings, LLC?
The company's name changed from Rallybio Holdings, LLC on May 2, 2018.
What is the fiscal year end for Rallybio Corp?
Rallybio Corp's fiscal year ends on December 31.
Filing Details
This Form 10-Q (Form 10-Q) was filed with the SEC on May 8, 2025 regarding Rallybio Corp (RLYB).